Your Directors hereby present the 32^nd Annual Report and Accounts of the Company for the year ended
31^st March, 2024.

Financial performance

The performance during the period ended 31^st March 2024 has been as under:

Performance

During the year under review, the Company has recorded loss of Rs. (10,40,418.98)/- and reported loss
of Rs. (12,45,917)/- in the previous financial year ending 31.03.2023.

Change in the nature of business

There was no change in nature of the business of the Company during the financial year ended on March
31,2024.

Secretarial Standards

Your Company has devised proper systems to ensure compliance with the provisions of all the applicable
Secretarial Standards issued by the Institute of Company Secretaries of India and that such systems are
adequate and operating effectively. During the year under review, your Company has complied with the
Secretarial Standards issued by the Institute of Company Secretaries of India.

Share Capital

The authorised share capital of the Company is Rs 25,00,00,000/- (Rupees Twenty Five Crores only)
divided into 2,50,00,000 (Two Crores Fifty Lakhs only) equity shares of Rs 10/- each.

Transfer to reserves

The company has not transferred any amount to reserves for the year.

Dividend

Your Board of Directors has not declared any dividend during the year.

Buy Back of shares

The Company has not bought back any of its securities during the financial year ended March 31,2024.
Indian Accounting Standards (Ind AS)

The Company has adopted Indian Accounting Standards (Ind AS). The standalone financial statements of
the Company forming part of the Annual Report have been prepared and presented in accordance with all
the material aspects of the Indian Accounting Standards (‘Ind AS’) as notified under section 133 of the
Companies Act 2013 read with the Companies (Indian Accounting Standards) Rules 2015 and relevant
amendment rules issued thereafter and guidelines issued by the Securities Exchange Board of India
(“SEBI”).

Deposits

The Company has not accepted any deposits from public in terms of Section 73 of the Companies Act,
2013 and as such, no amount on account of principal or interest on public deposits was outstanding as on
the date of the balance sheet.

Significant and material orders passed by the regulators

There are no significant or material orders passed by the Regulators/Courts which would impact the going
concern status of your Company and its future operations.

Material changes and commitments

There were no material changes and commitments, affecting the financial position of the Company
between the end of the financial year March 31, 2024, to which the financial statements relates and the
date of signing of this report.

Board of Directors

During the year under review, there was no change in the Board of Directors of the Company.

Key Managerial Personnel

During the year under review, there was no change in the KMP’s of the Company
Declaration by the Independent Directors

The Company has received declarations from all the Independent Directors of the Company confirming
that they continue to meet the criteria of independence, as prescribed under Section 149 of the
Companies Act, 2013, rules made there under and Regulations 16 & 25 of the Listing Regulations. The
Independent Directors have also confirmed that they have complied with the Company’s code of conduct.

Nomination and Remuneration Policy

Pursuant to the provisions of Section 178(3) of the Companies Act, 2013, and Regulation 19 of the Listing
Regulations, the Nomination and Remuneration Committee has formulated a policy relating to the
nomination and remuneration for the Directors and the Key Managerial Personnel (KMP). The current
policy is to have an appropriate mix of executive, non-executive and independent directors to maintain the
independence of the Board and separate its functions of governance and management. The policy of the
Company on directors’ appointment and remuneration, including criteria for determining qualifications,
positive attributes, independence of a director and other matters are adopted as per the provisions of the

Companies Act, 2013. The detailed policy is available on the Company’s website at
www.dolphinmedicalservices.com

Board Evaluation

The parameters and the process for evaluation of the performance of the Board and its Committees have
been explained in the Corporate Governance Report.

Familiarisation Programme

In terms of Clause 25(7) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, details of the familiarization programme of the Independent Directors are available on the website
of the Company at www.dolphinmedicalservices.com

Meetings of the Board of Directors

The Board of Directors of the Company duly met Six (6) times) during the financial year. The intervening
gap between any two meetings was within the prescribed period. The details of the Board meetings are
given in the Corporate Governance Report.

Committees of the Board

We have in place all the Committees of the Board which are required to be constituted under the
Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. A
detailed note on the Board and its Committees is provided under the Corporate Governance Report
section in this Board’s Report.

Subsidiary, Associate and Joint Venture Companies

There are no Subsidiaries, Associates and Joint Ventures as at the end of the financial year March 31,
2024.

Statutory Auditors

At the 31^st AGM of the Company, the members approved appointment of M/s. SMV & Co. Chartered
Accountants, Hyderabad having Firm registration number 015630S as Statutory Auditor of the Company
for a period of 5 years from the conclusion of that AGM.

The Auditors’ Report for FY 2023-24 does not contain any qualification, reservation or adverse remark.
The Report is enclosed with the financial statements in this Annual Report.

Internal Auditors

In pursuance of Section 138 of the Companies Act, 2013 read with rules made there under, the Board
has appointed Smt. M. Lakshmi Sudha, CFO of the Company as Internal Auditors of the Company to
carry out internal auditing of books of accounts periodically.

Cost Audit

Pursuant to Section 148(1) of the Companies Act, 2013, Cost Audit is not applicable to the Company for
the financial year ended March 31,2024.

Details of remuneration during the year 2023-24 as per Rule 5(1) of the Companies (Appointment &
Remuneration of Managerial Personnel) Rules 2015 are as follows:

A statement showing the details of remuneration is provided in Annexure III to this report.

Secretarial Auditors

Pursuant to the provisions of Section 204 of the Companies Act, 2013 and the Companies (Appointment
and Remuneration of Managerial Personnel) Rules 2014, the Board had appointed Mr. Bharatiraju
Vegiraju (COP Number: 14926) Practicing Company Secretary as Secretarial Auditors to conduct
Secretarial audit of the Company for the FY 2023-24.

The Secretarial Audit Report issued by Mr. Bharatiraju Vegiraju, Practicing Company Secretary in form
MR-3 is enclosed as Annexure - IV to this Annual Report.

Corporate Social Responsibility (CSR)

During the year under review, the provisions of the section 135 of the Companies Act, 2013 are not
applicable to the Company.

Management Discussion and Analysis Report

In terms of the provisions of Regulation 34 of the Listing Regulations, the Management Discussion and
Analysis Report highlighting the industry structure and developments, opportunities and threats, outlook,
risks and concerns etc. is annexed as Annexure-V of this Annual Report.

Corporate Governance

“Report on Corporate Governance” along with the Auditors’ Certificate on Corporate Governance as
stipulated under Regulation 34 read with Schedule V of Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 enclosed as Annexure-VI.

Statement containing additional information as required under Schedule V of the Companies Act,
2013

A statement containing additional information as required under Clause IV of Section II of Part II of
Schedule V of the Companies Act, 2013 is provided in the Report on Corporate Governance, which forms
part of this Annual Report.

Risk Management

During the year, the risk assessment parameters were reviewed and modified. The audit committee
reviewed the element of risks and the steps taken to mitigate the risks. In the opinion of the Board, there
are no major elements of risk which have the potential of threatening the existence of the Company.

The audit committee provides the framework of Risk Management by describing mechanisms for the
proactive identification and prioritization of risks based on the scanning of the external environment and
continuous monitoring of internal risk factors.

Analysis of the risks identified is carried out by way of focused discussion at the meetings of the Board.
The robust governance structure has also helped in the integration of the Enterprise Risk Management
process with the Company’s strategy and planning processes where emerging risks are used as inputs in
the strategy and planning process. Identified risks are used as one of the key inputs in the strategy and
business plan.

Internal Financial Control Systems and their adequacy

The Board has adopted policies and procedures for ensuring the orderly and efficient conduct of its
business, including adherence to the Company’s policies, safeguarding of its assets, prevention and
detection of fraud, error reporting mechanisms, accuracy and completeness of the accounting records,
and timely preparation of reliable financial disclosures.

Based on the framework of internal financial controls and compliance systems established and
maintained by the Company, including the audit of internal financial controls over financial reporting by
the statutory auditors and the reviews performed by management and the relevant board committees,
including the audit committee, the Board is of the opinion that the Company’s internal financial controls
were adequate and effective during FY 2023-24. Please refer Internal control systems and adequacy” in
the Management Discussion and Analysis report.

Consolidated financial statements

The Company has prepared the financial statements for the financial year ended March 31, 2024 on
standalone basis, since there were no subsidiaries or associates of the Company as at the end of the
FY 2023-24.

Whistle blower Policy/Vigil Mechanism

Pursuant to the requirement of the Companies Act, 2013 and of Regulation 22 of SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, the Company has a Whistle Blower Policy
and has established the necessary vigil mechanism for directors and employees to report concerns about
unethical behavior. The said Policy provides for adequate safeguard against victimization of
directors/employees who avail of such mechanism and provides access to the Chairman of Audit
Committee in exceptional cases. No person has been denied access to the Chairman of the Audit
Committee. The Whistle Blower Policy has been placed on website of the Company and web link thereto
is www.dolphinmedicalservices.com. During the year, there were no whistle blower complaints received
by the Company.

Reporting of Fraud by the Auditors

During the year under review, the Statutory Auditors and Secretarial Auditors of the Company have not
reported any instances of frauds committed in the Company by its officers or employees to the Audit
Committee under Section 143(12) of the Companies Act, 2013 details of which need to be mentioned in
this Report.

Annual Return

Pursuant to Section 92(3) read with Section 134(3)(a) of the Act, the Annual Return as on March 31,2024
will be uploaded on the Company’s website at www.dolphinmedicalservices.com.

Prevention of Sexual Harassment of Women at Workplace

The Company has adopted policy on Prevention of Sexual Harassment of Women at Workplace in
accordance with The Sexual Harassment of Women at Workplace (Prevention, Prohibition and
Redressal) Act, 2013.

The Company has always provided a safe and harassment free workplace for every individual working in
its premises through various policies and practices. The company always endeavors to create and
provide an environment that is free from discrimination and harassment including sexual harassment. The
Company has been actively involved in ensuring that the employees are aware of the provisions of the

POSH Act and rights thereunder. In the year under review, the Company has not received any such
complaint from any employee.

Particulars of Loans, Guarantees or Securities or Investments

The Company has not given loans / guarantees or made any investments during the year under review.
Related party transactions

All transactions entered with related parties for the year under review were on arm’s length basis and in
the ordinary course of business. There were no materially significant related party transactions made by
the Company with Promoters, Directors, Key Managerial Personnel or other designated persons which
may have a potential conflict with the interest of the Company at large. All related party transactions are
placed before the Audit Committee and also before the Board for approval, where ever required. The
Company has developed a Policy on Related Party Transactions for the purpose of identification and
monitoring of such transactions. The policy on Related Party Transactions as approved by the Board is
uploaded on the Company’s website www.dolphinmedicalservices.com.

The particulars of contracts or arrangements with related parties referred to in sub-section (1) of section
188 is prepared in Form AOC-2 pursuant to clause (h) of the Companies (Accounts) Rules, 2014 and the
same is annexed herewith as Annexure-II to this Report.

Particulars in respect of conservation of energy, technology absorption, foreign exchange
earnings and outgo

The information on Conservation of Energy, Technology Absorption, Foreign Exchange Earnings and
outgo required to be disclosed under Section 134(3)(m) of the Companies Act, 2013, read with Rule 8 of
the Companies (Accounts) Rules, 2014 are provided in the Annexure-I forming part of this Report.

Human Resources

Employees are our most valuable assets and key to the success of your Company. We are committed to
hiring and retaining the best talent. We always strive towards collaborative, transparent and participative
organization culture, and reward individual contribution and innovation.

Directors’ responsibility statement

Pursuant to the requirement under Section 134 of the Companies Act, 2013 with respect to the Directors'
Responsibility Statement, the Board of Directors of the Company hereby confirms;

i. in the preparation of the annual accounts, the applicable accounting standards have been followed
along with proper explanation relating to material departures;

ii. such accounting policies as mentioned in the notes to the financial statements have been selected and
applied consistently and judgments and estimates that are reasonable and prudent made so as to give a
true and fair view of the state of affairs of the Company at the end of the financial year 2023-24 and of the
statement of profit of the Company for that period;

iii. proper and sufficient care has been taken for the maintenance of adequate accounting records in
accordance with the provisions of the Companies Act, 2013 for safeguarding the assets of the Company
and for preventing and detecting fraud and other irregularities;

iv. the annual accounts for the year 2023-24 have been prepared on a going concern basis.

v. that the Directors, had laid down internal financial controls to be followed by the Company that such
internal financial controls were adequate and were operating effectively.

vi. that system to ensure compliance with the provisions of all applicable laws were in place and were
adequate and operating effectively.

Cautionary Statement

Statements in this Report, particularly those which relate to Management Discussion and Analysis as
explained in the Corporate Governance Report, describing the Company’s objectives, projections,
estimates and expectations may constitute ‘forward looking statements’ within the meaning of applicable
laws and regulations. Actual results might differ materially from those either expressed or implied in the
statement depending on the circumstances.

Acknowledgement

The Board of Directors takes this opportunity to place on record its appreciation to all the stakeholders of
the Company, viz., customers, investors, banks, regulators, suppliers and other business associates for
the support received from them during the year under review. The Directors also wish to place on record
their deep sense of gratitude and appreciation of all the employees for their commitment and contribution
towards achieving the goals of the Company.

For and on behalf of the Board
Dolphin Medical Services Limited

Place: Hyderabad Sd/- Sd/-

Date: 05.10.2024 Dr. Mohan Prasad GV Dr. Lakshmi Sudha M

Managing Director Director

DIN:01236113 DIN: 01235522